Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2
10.1007/s00418-012-0984-6
Crossref journal-article
Springer Science and Business Media LLC
Histochemistry and Cell Biology (297)
Bibliography

Giagnacovo, M., Malatesta, M., Cardani, R., Meola, G., & Pellicciari, C. (2012). Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2. Histochemistry and Cell Biology, 138(4), 699–707.

Authors 5
  1. M. Giagnacovo (first)
  2. M. Malatesta (additional)
  3. R. Cardani (additional)
  4. G. Meola (additional)
  5. C. Pellicciari (additional)
References 48 Referenced 11
  1. Andrade LE, Tan EM, Chan EK (1993) Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc Natl Acad Sci USA 90:1947–1951 (10.1073/pnas.90.5.1947) / Proc Natl Acad Sci USA by LE Andrade (1993)
  2. Bachinski LL, Udd B, Meola G, Sansone V, Bassez G, Eymard B, Thornton CA, Moxley RT, Harper PS, Rogers MT, Jurkat-Rott K, Lehmann-Horn F, Wieser T, Gamez J, Navarro C, Bottani A, Kohler A, Shriver MD, Sallinen R, Wessman M, Zhang S, Wright FA, Krahe R (2003) Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Gen 73:835–848 (10.1086/378566) / Am J Hum Gen by LL Bachinski (2003)
  3. Biggiogera M, Pellicciari C (2000) Heterogeneous ectopic RNP-derived structures (HERDS) are markers of transcriptional arrest. FASEB J 14:828–834 (10.1096/fasebj.14.5.828) / FASEB J by M Biggiogera (2000)
  4. Biggiogera M, Bottone MG, Scovassi AI, Soldani C, Vecchio L, Pellicciari C (2004) Rearrangement of nuclear ribonucleoprotein (RNP)-containing structures during apoptosis and transcriptional arrest. Biol Cell 96:603–615 (10.1016/j.biolcel.2004.04.013) / Biol Cell by M Biggiogera (2004)
  5. Biggiogera M, Cisterna B, Bottone MG, Soldani C, Pellicciari C (2007) Nuclear RNP and nucleolar-associated proteins during apoptosis: a politically correct form of segregation? Dynamic Cell Biol 1:65–71 / Dynamic Cell Biol by M Biggiogera (2007)
  6. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, Aburatani H, Hunter K, Stanton VP, Thirion JP, Hudson T, Sohn R, Zemelman B, Snell RG, Rundle SA, Crow S, Davies J, Shelbourne P, Buxton J, Jones C, Juvonen V, Johnson K, Harper PS, Shaw DJ, Housman DE (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 69:385–387 / Cell by JD Brook (1992)
  7. Cardani R, Mancinelli E, Sansone V, Rotondo G, Meola G (2004) Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy. Eur J Histochem 48:437–442 (10.4081/918) / Eur J Histochem by R Cardani (2004)
  8. Cardani R, Mancinelli E, Rotondo G, Sansone V, Meola G (2006) Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 50:177–182 / Eur J Histochem by R Cardani (2006)
  9. Cardani R, Mancinelli E, Giagnacovo M, Sansone V, Meola G (2009) Ribonuclear inclusions as biomarker of myotonic dystrophy type 2, even in improperly frozen or defrozen skeletal muscle biopsies. Eur J Histochem 53:107–112 (10.4081/ejh.2009.e13) / Eur J Histochem by R Cardani (2009)
  10. Chen YC, Kappel C, Beaudouin J, Eils R, Spector DL (2008) Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis. Mol Biol Cell 19:3147–3162 (10.1091/mbc.E08-01-0035) / Mol Biol Cell by YC Chen (2008)
  11. Day JW, Roelofs R, Leroy B, Pech I, Benzow K, Ranum LP (1999) Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord 9:19–27 (10.1016/S0960-8966(98)00094-7) / Neuromuscul Disord by JW Day (1999)
  12. Day JW, Ricker K, Jacobsen JF, Rasmussen LJ, Dick KA, Kress W, Schneider C, Koch MC, Beilman GJ, Harrison AR, Dalton JC, Ranum LP (2003) Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 60:657–664 (10.1212/01.WNL.0000054481.84978.F9) / Neurology by JW Day (2003)
  13. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira Smith O, Peacocke M, Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92:9363–9367 (10.1073/pnas.92.20.9363) / Proc Natl Acad Sci USA by GP Dimri (1995)
  14. Dundr M (2011) Seed and grow: a two-step model for nuclear body biogenesis. J Cell Biol 193:605–606 (10.1083/jcb.201104087) / J Cell Biol by M Dundr (2011)
  15. Fakan S (2004) The functional architecture of the nucleus as analysed by ultrastructural cytochemistry. Histochem Cell Biol 122:83–93 (10.1007/s00418-004-0681-1) / Histochem Cell Biol by S Fakan (2004)
  16. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, Harper PS, Brook JD (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11:805–814 (10.1093/hmg/11.7.805) / Hum Mol Genet by M Fardaei (2002)
  17. Fu YH, Pizzuti A, Fenwick RG Jr, King J, Rajnarayan S, Dunne PW, Dubel J, Nasser GA, Ashizawa T, de Jong P, Wieringa B, Korneluk R, Perryman MB, Epstein HF, Caskey CT (1992) An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256–1258 (10.1126/science.1546326) / Science by YH Fu (1992)
  18. Hayflick L, Moorhead PS (1961) The serial cultivation of human diploid cell strains. Exp Cell Res 25:585–621 (10.1016/0014-4827(61)90192-6) / Exp Cell Res by L Hayflick (1961)
  19. Holt I, Jacquemin V, Fardaei M, Sewry CA, Butler-Browne GS, Furling D, Brook JD, Morris GE (2009) Muscleblind-like proteins: similarities and differences in normal and myotonic dystrophy muscle. Am J Pathol 174:216–227 (10.2353/ajpath.2009.080520) / Am J Pathol by I Holt (2009)
  20. Jones K, Jin B, Iakova P, Huichalaf C, Sarkar P, Schneider-Gold C, Schoser B, Meola G, Shyu AB, Timchenko N, Timchenko L (2011) RNA Foci, CUGBP1, and ZNF9 are the primary targets of the mutant CUG and CCUG repeats expanded in myotonic dystrophies type 1 and type 2. Am J Pathol. doi: 10.1016/j.ajpath.2011.07.013 (in press) / Am J Pathol by K Jones (2011)
  21. Ladd AN, Charlet N, Cooper TA (2001) The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing. Mol Cell Biol 21:1285–1296 (10.1128/MCB.21.4.1285-1296.2001) / Mol Cell Biol by AN Ladd (2001)
  22. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, Naylor SL, Day JW, Ranum LP (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293:864–867 (10.1126/science.1062125) / Science by CL Liquori (2001)
  23. Llorian M, Smith CW (2011) Decoding muscle alternative splicing. Curr Opin Genet Dev 21:380–387 (10.1016/j.gde.2011.03.006) / Curr Opin Genet Dev by M Llorian (2011)
  24. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, Jansen G, Neville C, Narang M, Barceló J, O’Hoy K, Leblond S, Earle-MacDonald J, de Jong PJ, Wieringa B, Korneluk RG (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253–1255 (10.1126/science.1546325) / Science by M Mahadevan (1992)
  25. Malatesta M, Zancanaro C, Martin TE, Chan EKL, Amalric F, Lührmann R, Vogel P, Fakan S (1994) Cytochemical and immunocytochemical characterization of nuclear bodies during hibernation. Eur J Cell Biol 65:82–93 / Eur J Cell Biol by M Malatesta (1994)
  26. Malatesta M, Cardinali A, Battistelli S, Zancanaro C, Martin TE, Fakan S, Gazzanelli G (1999) Nuclear bodies are usual constituents in tissues of hibernating dormice. Anat Rec 254:389–395 (10.1002/(SICI)1097-0185(19990301)254:3<389::AID-AR10>3.0.CO;2-E) / Anat Rec by M Malatesta (1999)
  27. Malatesta M, Giagnacovo M, Cardani R, Meola G, Pellicciari C (2011) RNA processing is altered in skeletal muscle nuclei of patients affected by myotonic dystrophy. Histochem Cell Biol 135:419–425 (10.1007/s00418-011-0797-z) / Histochem Cell Biol by M Malatesta (2011)
  28. Mankodi A, Teng-Umnuay P, Krym M, Henderson D, Swanson M, Thornton CA (2003) Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 54:760–768 (10.1002/ana.10763) / Ann Neurol by A Mankodi (2003)
  29. Mehta IS, Figgitt M, Clements CS, Kill IR, Bridger JM (2007) Alterations to nuclear architecture and genome behavior in senescent cells. Ann NY Acad Sci 1100:250–263 (10.1196/annals.1395.027) / Ann NY Acad Sci by IS Mehta (2007)
  30. Meola G, Moxley RT 3rd (2004) Myotonic dystrophy type 2 and related myotonic disorders. J Neurol 251:1173–1182 (10.1007/s00415-004-0590-1) / J Neurol by G Meola (2004)
  31. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, Thornton CA, Swanson MS (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 19:4439–4448 (10.1093/emboj/19.17.4439) / EMBO J by JW Miller (2000)
  32. Moxley RT, Meola G (2008) The myotonic dystrophies. Chapter 47. In: Rosenberg RN, Di Mauro S, Paulson HL, Ptacek L, Nestler EJ (eds) The molecular and genetic basis of neurologic and psychiatric disease, 4th edn. Lippincot Williams, Philadelphia / The molecular and genetic basis of neurologic and psychiatric disease by RT Moxley (2008)
  33. Mulders SAM, van den Broek WJAA, Wheeler TM, Croes HJE, van Kuik-Romeijn P, de Kimpe SJ, Furling D, Platenburg GJ, Gourdon G, Thornton CA, Wieringa B, Wansink DG (2009) Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy. Proc Natl Acad Sci USA 106:13915–13920 (10.1073/pnas.0905780106) / Proc Natl Acad Sci USA by SAM Mulders (2009)
  34. Perdoni F, Malatesta M, Cardani R, Giagnacovo M, Mancinelli E, Meola G, Pellicciari C (2009) RNA/MBNL1-containing foci in myoblast nuclei from patients affected by myotonic dystrophy type 2: an immunocytochemical study. Eur J Histochem 53:151–158 (10.4081/ejh.2009.e18) / Eur J Histochem by F Perdoni (2009)
  35. Querido E, Gallardo F, Beaudoin M, Ménard C, Chartrand P (2011) Stochastic and reversible aggregation of mRNA with expanded CUG-triplet repeats. J Cell Sci 124:1703–1714 (10.1242/jcs.073270) / J Cell Sci by E Querido (2011)
  36. Ranum LP, Rasmussen PF, Benzow KA, Koob MD, Day JW (1998) Genetic mapping of a second myotonic dystrophy locus. Nat Genet 19:196–198 (10.1038/570) / Nat Genet by LP Ranum (1998)
  37. Rubin H (1997) Cell aging in vivo and in vitro. Mech Ageing Dev 98:1–35 (10.1016/S0047-6374(97)00067-5) / Mech Ageing Dev by H Rubin (1997)
  38. Savkur RS, Philips AV, Cooper TA (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 29:40–47 (10.1038/ng704) / Nat Genet by RS Savkur (2001)
  39. Savkur RS, Philips AV, Cooper TA, Dalton JC, Moseley ML, Ranum LP, Day JW (2004) Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 74:1309–1313 (10.1086/421528) / Am J Hum Genet by RS Savkur (2004)
  40. Schoser B, Timchenko L (2010) Myotonic dystrophies 1 and 2: complex diseases with complex mechanisms. Curr Genomics 11:77–90 (10.2174/138920210790886844) / Curr Genomics by B Schoser (2010)
  41. Sikora E, Arendt T, Bennett M, Narita M (2011) Impact of cellular senescence signature on ageing research. Ageing Res Rev 10:146–152 (10.1016/j.arr.2010.10.002) / Ageing Res Rev by E Sikora (2011)
  42. Smolinski DJ, Wrobel B, Noble A, Zienkiewicz A, Gorska-Brylass A (2011) Periodic expression of Sm proteins parallels formation of nuclear Cajal bodies and cytoplasmic snRNP-rich bodies. Histochem Cell Biol 136:527–541 (10.1007/s00418-011-0861-8) / Histochem Cell Biol by DJ Smolinski (2011)
  43. Suominen T, Bachinski LL, Auvinen S, Hackman P, Baggerly KA, Angelini C, Peltonen L, Krahe R, Udd B (2011) Population frequency of myotonic dystrophy: higher than expected frequency of myotonic dystrophy type 2 (DM2) mutation in Finland. Eur J Hum Gen 19:776–782 (10.1038/ejhg.2011.23) / Eur J Hum Gen by T Suominen (2011)
  44. Udd B, Meola G, Krahe R, Wansink DG, Bassez G, Kress W, Schoser B, Moxley R (2011) Myotonic dystrophy type 2 (DM2) and related disorders. Neuromusc Disord 21:443–450 (10.1016/j.nmd.2011.03.013) / Neuromusc Disord by B Udd (2011)
  45. Vihola A, Bassez G, Meola G, Zhang S, Haapasalo H, Paetau A, Mancinelli E, Rouche A, Hogrel JY, Laforêt P, Maisonobe T, Pellissier JF, Krahe R, Eymard B, Udd B (2003) Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 60:1854–1857 (10.1212/01.WNL.0000065898.61358.09) / Neurology by A Vihola (2003)
  46. Wang G-S, Kearney DL, De Biasi M, Taffet G, Cooper TA (2007) Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 117:2802–2811 (10.1172/JCI32308) / J Clin Invest by G-S Wang (2007)
  47. Warf MB, Nakamori M, Matthys CM, Thornton CA, Berglund JA (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy. Proc Natl Acad Sci USA 106:18551–18556 (10.1073/pnas.0903234106) / Proc Natl Acad Sci USA by MB Warf (2009)
  48. White AE, Leslie ME, Calvi BR, Marzluff WF, Duronio RJ (2007) Developmental and cell cycle regulation of the drosophila histone locus body. Mol Biol Cell 18:2491–2502 (10.1091/mbc.E06-11-1033) / Mol Biol Cell by AE White (2007)
Dates
Type When
Created 13 years ago (July 26, 2012, 9:11 p.m.)
Deposited 6 years, 1 month ago (July 1, 2019, 3:23 p.m.)
Indexed 1 year, 3 months ago (May 22, 2024, 10:49 p.m.)
Issued 13 years, 2 months ago (June 17, 2012)
Published 13 years, 2 months ago (June 17, 2012)
Published Online 13 years, 2 months ago (June 17, 2012)
Published Print 12 years, 10 months ago (Oct. 1, 2012)
Funders 0

None

@article{Giagnacovo_2012, title={Nuclear ribonucleoprotein-containing foci increase in size in non-dividing cells from patients with myotonic dystrophy type 2}, volume={138}, ISSN={1432-119X}, url={http://dx.doi.org/10.1007/s00418-012-0984-6}, DOI={10.1007/s00418-012-0984-6}, number={4}, journal={Histochemistry and Cell Biology}, publisher={Springer Science and Business Media LLC}, author={Giagnacovo, M. and Malatesta, M. and Cardani, R. and Meola, G. and Pellicciari, C.}, year={2012}, month=jun, pages={699–707} }